GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Parexel International Corporation (PRXL) [hlAlert]

Rating:
Outperform
PRXL
up 41.09 %

Parexel International Corporation (PRXL) rated Outperform by Credit Suisse

Posted on: Tuesday,  Sep 24, 2013  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Parexel International Corporation (NASDAQ: PRXL) on 09/24/2013, when the stock price was $49.06. Since
then, Parexel International Corporation has gained 41.09% as of 01/25/2016's recent price of $69.22.
If you would have followed this Credit Suisse's recommendation on PRXL, you would have gained 41.09% of your investment in 853 days.

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/24/2013 8:25 AM Buy
None
49.06
as of 12/13/2013
1 Week up  1.84 %
1 Month down  -4.25 %
3 Months down  -14.67 %
1 YTD down  -14.67 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy